How many insider trades does FilingIQ track for SER?

FilingIQ tracks 156 Form 4 insider transactions for SER (Serina Therapeutics, Inc.), covering filings from May 17, 2024 onwards. 8 of those were filed in the last 90 days.

Are SER insiders net buyers or net sellers?

Across the full Form 4 history for SER, 30 transactions (19%) were open-market purchases and 41 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SER insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is SER in?

Serina Therapeutics, Inc. (SER) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $18.34M.

SER insider trading

Healthcare

Serina Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

156

Last 90 days

Buys / sells

19% / 26%

Market cap

$18.34M

About Serina Therapeutics, Inc.

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.

Company website: serinatherapeutics.com

SER insider activity at a glance

FilingIQ has scored 156 insider transactions for SER since May 17, 2024. The most recent filing in our index is dated Mar 31, 2026.

Across the full history, 30 open-market purchases and 41 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SER insider trades is 48.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SER trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for SER?: FilingIQ tracks 156 Form 4 insider transactions for SER (Serina Therapeutics, Inc.), covering filings from May 17, 2024 onwards. 8 of those were filed in the last 90 days.
Are SER insiders net buyers or net sellers?: Across the full Form 4 history for SER, 30 transactions (19%) were open-market purchases and 41 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SER insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is SER in?: Serina Therapeutics, Inc. (SER) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $18.34M.

Methodology & sources

Every SER insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.